🔹 Adj EPS: $7.20 (Est. $7.15) 🟢; UP +7% YoY
🔹 Revenue: $67.13B (Est. $62.46B) 🟢; UP +11% YoY
FY25 Guidance
🔹 Adj EPS: At least $29.60 (Est. $29.68) 🔴
🔹 Cigna Healthcare MCR: 83.2% – 84.2%
Q2 Evernorth Health Services
🔹 Adjusted Revenue: $57.83B; UP +17% YoY
🔹 Pharmacy Benefit Services: $31.95B; UP +20% YoY
🔹 Specialty & Care Services: $25.87B; UP +13% YoY
🔹 Adjusted Operating Income (pre-tax): $1.70B; UP +5% YoY
🔹 PBS Income: $833M; UP +2% YoY
🔹 Specialty & Care Services Income: $863M; UP +7% YoY
🔹 Pre-tax Margin: 2.9% (vs. 3.3% YoY)
Q2 Cigna Healthcare
🔹 Adj Revenue: $10.75B; DOWN -18% YoY (impacted by HCSC divestiture)
🔹 Ex-HCSC: UP +7% YoY
🔹 Adjusted Operating Income (pre-tax): $1.09B; DOWN -9% YoY
🔹 Medical Care Ratio (MCR): 83.2% (vs. 82.3% YoY)
Other Metrics
🔹 Total Revenues: $67.2B; UP +11% YoY
🔹 SG&A Expense Ratio: 5.1% (vs. 6.1% YoY)
🔹 Adjusted SG&A Expense Ratio: 4.9% (vs. 6.0% YoY)
🔹 Total Medical Customers: 18.05M; DOWN -6% YTD
🔹 Pharmacy Customers: 121.89M; UP +3% YTD
🔹 Total Customer Relationships: 182.2M; UP +2% YTD (ex-HCSC impact)
CEO Commentary
🔸 “Our performance in the second quarter reflects our disciplined execution and the strength of our business mix.”
🔸 “Listening, adapting, and innovating to meet the evolving needs of our patients, customers, and clients enables us to deliver meaningful value.”